D-0651-2020 Class II Terminated
FDA drug recall D-0651-2020 was initiated by Asclemed USA Inc. Dba Enovachem Pharmaceuticals on Dec 9, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results. The recall status is terminated (terminated Aug 9, 2023). Affected quantity: 42.12 gm.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 15, 2020
- Initiation Date
- Dec 9, 2019
- Termination Date
- Aug 9, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 42.12 gm
Product description
Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-37
Reason for recall
Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.
Distribution pattern
Product was distributed to 6 physician's offices within the state of California.
Code information
Lot Code/Exp. Date: 11061901, 11061803, 11281804, 11291804, 04171902, 05201901, 08121902, EXP 12/31/2020; 08161901, 10111903, EXP 5/31/2021; 11211904, 10161901, EXP 8/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0651-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026